Even though we do not know the exact mechanisms driving SURF1 overexpression toxicity or the toxicity related to other mitochondrial proteins, these observations warrant caution that extra care may be required with the design of mitochondrial disease gene therapies. The gene discussed is SURF1; the disease is mitochondrial disease.